Thread- Reinforced Encapsulation Devices (THRED) for Therapeutic Stem Cell Delivery
Topic overview
This article presents a novel thread-reinforced encapsulation device (THRED) designed to protect mesenchymal stem cells from immune destruction while enabling therapeutic delivery. The technology addresses key barriers to MSC therapy—tumorigenic risk and poor cell survival—with specific application to treating intestinal ischemic conditions.
Key takeaways
- MSC encapsulation addresses two key barriers: risk of tumorigenic transformation and immune-mediated destruction in host tissue.
- Thread-reinforced encapsulation devices (THRED) offer a novel delivery method for therapeutic stem cells in clinical applications.
- This approach may enable MSC therapy for intestinal ischemic diseases by protecting cells while maintaining therapeutic function.
- Encapsulation technology could extend MSC longevity in vivo by shielding them from host immune responses.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Thread- Reinforced Encapsulation Devices (THRED) for Therapeutic Stem Cell Delivery. GlobalCastMD Medical Library. 2026-05-06. https://library.globalcastmd.com/article/12006
Comments